Skip to main content
Signal8

Chinoporos Constantine

SEC insider (Form 3/4/5 filer). CIK 0002014509. Interim Chief Business Officer at enGene Therapeutics Inc. (ENGN) and 2 other issuers. 7 reported Form 4/5 transactions since Sep 2024; latest on Mar 25, 2026. Located in FOSTER CITY, CA.

Companies Chinoporos Constantine has filed insider reports for

  • enGene Therapeutics Inc. (ENGN): Officer, Interim Chief Business Officer
  • GERON CORP (GERN): Director
  • Applied Therapeutics, Inc. (APLT): Officer, See Remarks
Chinoporos Constantine profile photo

Chinoporos Constantine

CIK: 0002014509

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (28.6%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)2 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

enGene Therapeutics Inc. logo
ENGN

enGene Therapeutics Inc.

Officer
GERON CORP logo
GERN

GERON CORP

Director
Applied Therapeutics, Inc. logo
APLT

Applied Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • GERON CORP logo
    GERN

    GERON CORP

    Mar 25, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    270K shares-
  • Applied Therapeutics, Inc. logo
    APLT

    Applied Therapeutics, Inc.

    Feb 3, 2026
    Disposition
    Direct
    1M shares-
  • Applied Therapeutics, Inc. logo
    APLT

    Applied Therapeutics, Inc.

    Feb 3, 2026
    Tender Offer
    Direct
    57.1K shares-
  • Applied Therapeutics, Inc. logo
    APLT

    Applied Therapeutics, Inc.

    Dec 19, 2025
    Award
    Direct
    437.5K shares-
  • Applied Therapeutics, Inc. logo
    APLT

    Applied Therapeutics, Inc.

    Mar 24, 2025
    Award
    Direct
    350K shares-
  • Applied Therapeutics, Inc. logo
    APLT

    Applied Therapeutics, Inc.

    Mar 4, 2025
    Sale
    Direct
    447 shares at avg. $0.44$196.68
  • Applied Therapeutics, Inc. logo
    APLT

    Applied Therapeutics, Inc.

    Feb 6, 2025
    Sale
    Direct
    28.1K shares at avg. $0.61$17K

1-7 of 7